[Hemo- and cardiodynamic changes in arterial hypertension patients as affected by alpha- and beta-adrenergic blockader therapy].

Abstract

It is shown that treatment of patients with arterial hypertension with obsidan reduces arterial pressure because of a decrease in cardiac output; in treatment with pyroxan the arterial pressure is reduced due to decrease in total peripheral vascular resistance. Combined treatment with alpha- and beta-adrenergic blocking agents allows arterial pressure to be normalized with much lesser doses because the interrelationships of the principal hemodynamic values are normalized.

• Authors: B Ia Zonis
• Journal: Kardiologiia (Kardiologiia) Vol. 21 Issue 3 Pg. 28-32 (Mar 1981) ISSN: 0022-9040 [Print] Russia (Federation)
• Vernacular Title: Izmeneniia gemo- i kardiodinamiki u bol'nykh s arterial'noĭ gipertenzieĭ pod vliianiem terapii al'fa- i beta-adrenoblokatorami.
• PMID: 6112285 (Publication Type: Comparative Study, English Abstract, Journal Article)

Chemical References

• Adrenergic alpha-Antagonists
• Adrenergic beta-Antagonists

Topics

• Adrenergic alpha-Antagonists (administration & dosage)
• Adrenergic beta-Antagonists (administration & dosage)
• Drug Evaluation
• Drug Therapy, Combination
• Heart (drug effects)
• Heart Function Tests
• Hemodynamics (drug effects)
• Humans
• Hypertension (drug therapy, physiopathology)
• Time Factors